Don’t Eat the Yellow Rice: The Danger of Deploying Vitamin A Golden Rice
By Ted Greiner,
Independent Science News
| 07. 11. 2016
What better way to discredit your critics than to rope in 107 naive Nobel Prize winners (all without relevant expertise) to criticize your opposition?
But such tactics are not new. Long ago, the GMO industry spent well over $50 million to promote “Golden Rice” as the solution to vitamin A deficiency in low income countries. They did so well before the technology was completely worked out, let alone tested. Let alone consumer acceptability tested. Let alone subjecting it to standard phase 2 and 3 trials to see if it could ever solve problems in the real world.
So why has this apparently straightforward scientific project not reached completion after so many decades?
Because the purpose of Golden Rice was never to solve vitamin A problems. It never could and never will. It’s purpose from the beginning was to be a tool for use in shaming GMO critics and now to convince Nobel Laureates to sign on to something they didn’t understand.
I worked with a conventional fortified rice technology (Ultra Rice) for years for the NGO PATH in...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...